


Minoryx Therapeutics raises €21.3M in Series B funding round

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102

Minoryx announces dosing of first US patient in phase 2/3 clinical study of MIN-102 (ADVANCE)

Inoviem Scientific enters into service-based partnership with XoNovo

Univercells raises EUR 16 million in Series B financing round led by Global Health Investment Fund

Yposkesi appoints Dr. Fraser Wright as senior advisor

ASM Microbe 2018: Nosopharm to present new first-in-class clinical candidate to tackle Enterobacteriaceae infections

Nosopharm renews its partnership with Inra
